Timepoint | Comparison | Mean difference | 95% CI of diff. | Significance |
---|---|---|---|---|
IgG | ||||
 Week 1 | PBS v PEI/pDNA | 10.40 | 4.20 to 16.61 | ** |
PBS v RALA/pDNA | 10.54 | 4.33 to 16.75 | ** | |
 Week 2 | PBS v PEI/pDNA | − 0.02 | − 6.23 to 6.20 | ns |
PBS v RALA/pDNA | 0.03 | − 6.18 to 6.24 | ns | |
 Week 3 | PBS v PEI/pDNA | − 13.89 | − 20.1 to − 7.68 | *** |
PBS v RALA/pDNA | − 5.07 | − 11.28 to 1.15 | ns | |
IgM | ||||
 Week 1 | PBS v PEI/pDNA | 2.66 | − 23.05 to 28.37 | ns |
PBS v RALA/pDNA | − 2.18 | − 27.89 to 23.52 | ns | |
 Week 2 | PBS v PEI/pDNA | − 10.44 | − 36.15 to 15.27 | ns |
PBS v RALA/pDNA | − 11.99 | − 37.7 to 13.72 | ns | |
 Week 3 | PBS v PEI/pDNA | − 30.79 | − 56.5 to − 5.08 | * |
PBS v RALA/pDNA | − 20.98 | − 46.69 to 4.73 | ns | |
Il-1β | ||||
 Week 1 | PBS v PEI/pDNA | 4.20 | − 3.29 to 11.69 | ns |
PBS v RALA/pDNA | 6.77 | − 0.72 to 14.26 | ns | |
 Week 2 | PBS v PEI/pDNA | − 1.94 | − 9.43 to 5.55 | ns |
PBS v RALA/pDNA | 4.19 | − 3.31 to 11.68 | ns | |
 Week 3 | PBS v PEI/pDNA | − 4.73 | − 12.22 to 2.76 | ns |
PBS v RALA/pDNA | − 3.27 | − 10.76 to 4.22 | ns | |
IL6 | ||||
 Week 1 | PBS v PEI/pDNA | − 27.61 | − 52.87 to − 2.35 | * |
PBS v RALA/pDNA | − 26.24 | − 51.50 to 0.97 | * | |
 Week 2 | PBS v PEI/pDNA | 10.61 | − 14.66 to 35.87 | ns |
PBS v RALA/pDNA | − 2.41 | − 27.67 to 22.85 | ns | |
 Week 3 | PBS v PEI/pDNA | 17.74 | − 7.52 to 43.00 | ns |
PBS v RALA/pDNA | 2.80 | − 22.47 to 28.06 | ns |